| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5acc73c34cf2b348b8bce69d72b9c37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d607d32ce3da33038adbbb3a2ab61da9 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 |
| filingDate |
2019-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ebb5e187ababd5c7cc91c0ab94d4fd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8878b8e10b8fe63bc5bd94955aeb206f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5b62585c0e6b594b5a1f29a2bf46be3 |
| publicationDate |
2020-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202034942-A |
| titleOfInvention |
Method of using peptide-based drug |
| abstract |
The present invention discloses a method of using peptide-based drug for preparing a medicament comprising a composition which inhibits the AKT signaling pathway. Moreover, the abovementioned peptide-based drug is also able to prepare a medicament comprising a composition which treats the pulmonary hypertension or inhibits the vascular remodeling. |
| priorityDate |
2019-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |